Rooted in China, to Become a World-Class Biopharmaceutical Enterprise
Manufacturing Bases
Shenyang Base—National High-Tech Enterprise
National Green Factory, Liaoning Provincial Green Factory
National Enterprise Technology Center, Industrialization Base for Achievements of the National High Technology Research and Development Program (863 Program)
Gold Award of Liaoning Provincial Governor’s Quality Award
Maximum annual capacity of 40 million vials/pre-filled syringes
Quality system certified by regulatory authorities in Brazil, Türkiye, Ukraine, and other countries; underwent an FDA on-site inspection in 2025
Products approved for marketing in more than 20 countries
Shanghai Base — National High-Tech Enterprise
National Green Factory, Shanghai Green Manufacturing Demonstration Factory
National Enterprise Technology Center; National Engineering Research Center for Antibody Drugs; State Key Laboratory of Immunity and Inflammation; Engineering Research Center of Cell Engineering and Antibody Drugs, Ministry of Education; Shanghai Innovative Enterprise Headquarters; Shanghai Antibody Technology Innovation Center; and Shanghai Antibody Engineering Technology Research Center
National Specialized, Refined, Distinctive, and Innovative “Little Giant” Enterprise; National Intellectual Property Demonstration Enterprise; and Pudong New Area Mayor Quality Award
The bioreactor has a capacity of 40,000 liters, making it one of the largest antibody drug production lines in China.
All existing production lines have obtained domestic GMP certification and GMP certification in eight overseas markets, including Mexico, Ukraine, Türkiye, Colombia, Indonesia, Brazil, Pakistan, and the Philippines; and have obtained two EU QP certifications.
Hangzhou Base — National High-Tech Enterprise
The only small-molecule drug R&D, manufacturing, and commercialization base under 3SBio
Zhejiang Provincial Enterprise Technology Center, Zhejiang Provincial Sci-Tech Little Giant Enterprise, Zhejiang Provincial Specialized, Refined, Distinctive and Innovative SME
Maximum annual capacity of 40 million bottles of tinctures/foams
Zhejiang Provincial Water-Saving Enterprise; Hangzhou Green and Low-Carbon Factory
13 production lines across six production workshops for two major dosage forms—topical preparations and solid preparations
Shenzhen Base — National High-Tech Enterprise
Shenzhen Bioengineering Industrialization Base; Shenzhen Specialized, Refined, Distinctive, and Innovative SME
Production lines certified under the latest Chinese GMP standards and Thailand FDA PIC/S Inspection requirements
Environmental management system certified to ISO 14001 standard
Maximum annual capacity: 75 million vials/prefilled syringes
CN
